- Home
- ANIP vs BKD Comparison
ANIP vs BKD Comparison
Compare ANIP & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- BKD
- Stock Information
- Founded
- ANIP 2001
- BKD 2005
- Country
- ANIP United States
- BKD United States
- Employees
- ANIP N/A
- BKD N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- BKD Hospital/Nursing Management
- Sector
- ANIP Health Care
- BKD Health Care
- Exchange
- ANIP Nasdaq
- BKD Nasdaq
- Market Cap
- ANIP 1.2B
- BKD 1.3B
- IPO Year
- ANIP N/A
- BKD 2005
- Fundamental
- Price
- ANIP $58.46
- BKD $5.00
- Analyst Decision
- ANIP Buy
- BKD Buy
- Analyst Count
- ANIP 7
- BKD 4
- Target Price
- ANIP $77.33
- BKD $7.50
- AVG Volume (30 Days)
- ANIP 254.4K
- BKD 1.8M
- Earning Date
- ANIP 02-27-2025
- BKD 02-18-2025
- Dividend Yield
- ANIP N/A
- BKD N/A
- EPS Growth
- ANIP N/A
- BKD N/A
- EPS
- ANIP N/A
- BKD N/A
- Revenue
- ANIP $555,456,000.00
- BKD $2,954,652,000.00
- Revenue This Year
- ANIP $25.48
- BKD $10.10
- Revenue Next Year
- ANIP $20.24
- BKD $4.24
- P/E Ratio
- ANIP N/A
- BKD N/A
- Revenue Growth
- ANIP 23.60
- BKD 5.20
- 52 Week Low
- ANIP $52.50
- BKD $4.71
- 52 Week High
- ANIP $70.81
- BKD $8.12
- Technical
- Relative Strength Index (RSI)
- ANIP 62.05
- BKD 43.28
- Support Level
- ANIP $52.74
- BKD $4.73
- Resistance Level
- ANIP $55.21
- BKD $5.13
- Average True Range (ATR)
- ANIP 1.54
- BKD 0.19
- MACD
- ANIP 0.48
- BKD 0.03
- Stochastic Oscillator
- ANIP 98.11
- BKD 51.82
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments; Independent Living; Assisted Living and Memory Care; and Continuing Care Retirement Communities (CCRs). Majority of the revenue is generated from the Assisted Living and Memory Care segment that offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees which it receives in exchange for the services provided, and in the form of management fee from certain communities under contract, in exchange for the management services provided.